Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry corresponds to a **pseudogene** of the NADH dehydrogenase [ubiquinone] 1 alpha subunit. Pseudogenes are genomic sequences similar to known genes but are generally considered *non-functional* because they contain mutations that prevent normal protein expression. They do not encode proteins or serve as therapeutic targets, and there is no evidence for their involvement in biological processes or diseases as functional molecules. "ENSG00000228373" is an Ensembl identifier for this pseudogene, also known as "LOC112268032." Because it is not a functional gene product, it is not classified as a receptor, enzyme, transporter, transcription factor, or any related molecular target category, nor is it associated with interacting drugs or disease mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] 1 alpha pseudogene.